Pharmaceuticals News

– Theriva recibió un pago inicial de 350 000 dólares estadounidenses al cierre de la operación y podrá optar a recibir hasta 91 millones de dólares en concepto de hitos reglamentarios y comerciales,...

WILMETTE, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments...

UroGen first patient dosed in UGN-501 Phase 1 trial

Oral tablet form expected to allow Company to optimize patient plasma exposure levels with convenient daily dosing of drug Sustained plasma levels of elraglusib expected to have multiple effects on...

Matt Franklin joins A3P Biomedical as President, North America to accelerate U.S. market access for Stockholm3.

WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis...

Predictive Interim analysis indicates low probability of study meeting its primary efficacy endpoint if continuedComprehensive analysis and evaluation of available open-label extension data will...

The SEC has declared effective the Form S-4 Registration Statement and definitive proxy for the proposed merger between Chemomab and Scipher Medicine.

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen...

In patients aged 64+: 79.2% of patients achieved a clinically meaningful response (reduced pain and improved knee function) in the Allocetra™ group vs. 47.6% in the placebo group at 12 months...